99 unknown. 99 Phase 1, 51 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 99 | Unknown 99 |
| Phase 2 | 51 | Unknown 51 |
Follow Stomach Diseases: new trials by email Literature Review of Stomach Diseases trials Research Report on Stomach Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric Cancer SOX+Tislelizumab+LDRT - Gastric Cancer | Phase 1 / Phase 2 | Unknown | West China Hospital | 64 | 2024-03-10 | 2024-02-20 |
| Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration Cisplatine Teva® - Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung | Phase 1 | Unknown | Dr Jean Yannis PERENTES | 39 | 2023-11-24 | 2024-02-28 |
| Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent PB101 - Solid Tumor, Adult, Solid Tumor | Phase 1 | Unknown | Panolos Bioscience | 30 | 2023-10-25 | 2024-02-23 |
| PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid Tumors CVL218 - Advanced Solid Tumor | Phase 1 / Phase 2 | Unknown | Fujian Cancer Hospital | 96 | 2023-10-10 | 2023-10-12 |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors CEA CAR-T cells - Gastric Cancer, Colon Cancer | Phase 1 | Unknown | Chongqing Precision Biotech Co., Ltd | 36 | 2023-09-30 | 2023-11-08 |
| CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors CEA-targeted CAR-T cells - Gastric Cancer, Colon Cancer | Phase 1 / Phase 2 | Unknown | Chongqing Precision Biotech Co., Ltd | 60 | 2023-09-07 | 2024-08-09 |
| Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) and Electrostatic PIPAC (ePIPAC) With Paclitaxel In Patients With Peritoneal Carcinomatosis Paclitaxel - Peritoneal Carcinomatosis | Phase 1 | Unknown | National University Hospital, Singapore | 36 | 2023-08-04 | 2024-05-29 |
| Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric Cancer Disitamab Vedotin, Toripalimab - Gastric Cancer, HER2-low-expressing Gastric Cancer | Phase 1 | Unknown | Shanghai East Hospital | 39 | 2023-06-06 | 2023-10-12 |
| Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes IBI315, Oxaliplatin, Capecitabine - Gastric Cancer, Gastroesophageal-junction Cancer | Phase 1 / Phase 2 | Unknown | Henan Cancer Hospital | 45 | 2023-01-01 | 2022-11-08 |
| Evaluation of the Safety and Efficacy of Esperanza Extract (PA001) Petiveria Alliacea Preparation, Placebo - Neoplasm, Stomach, Gastric Neoplasms Malignant | Phase 1 / Phase 2 | Unknown | Hospital Universitario San Ignacio | 82 | 2022-12-15 | 2022-10-19 |
| Clinical Study of VG161 Combined With Nivolumab Injection in Patients With Advanced Metastatic Gastric Cancer Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), Nivolumab Injection - Metastatic Gastric Cancer | Phase 1 / Phase 2 | Unknown | CNBG-Virogin Biotech (Shanghai) Ltd. | 43 | 2022-11-17 | 2023-08-24 |
| Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor Trametinib treatment, Endoscopy - Gastric Cancer, Metaplasia | Phase 1 | Unknown | Vanderbilt-Ingram Cancer Center | 15 | 2022-11-09 | 2024-07-31 |
| Selinexor in Combination With R-CHOP Followed by Selinexor Maintenance for Untreated EBV-positive DLBCL Patients Selinexor, R-CHOP Protocol - EBV-Positive Diffuse Large B-Cell Lymphoma, Nos | Phase 1 / Phase 2 | Unknown | Sun Yat-sen University | 54 | 2022-11-01 | 2023-12-14 |
| Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas APG-5918 - Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer | Phase 1 | Unknown | Ascentage Pharma Group Inc. | 90 | 2022-09-30 | 2022-11-16 |
| To Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Disitamab Vedotin Combined With RC98 in the Treatment of Subjects With HER2-expressing Locally Advanced or Metastatic Gastric Cancer (Including AEG) RC48-ADC, RC98 - Gastric Cancer | Phase 1 | Unknown | RemeGen Co., Ltd. | 24 | 2022-09-28 | 2023-12-18 |
| Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression Claudin 18.2 CAR-T - Gastric Cancer, Pancreatic Cancer | Phase 1 | Unknown | Suzhou Immunofoco Biotechnology Co., Ltd | 30 | 2022-08-08 | 2024-03-06 |
| A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric Cancer Oxaliplatin, Teysuno, Transarterial arterial chemoinfusion and embolism (TACiE) - Gastric Cancer | Phase 1 | Unknown | Shanghai Zhongshan Hospital | 20 | 2022-06-01 | 2022-05-31 |
| Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma fruquintinib＋toripalimab + SOX - Metastatic Gastric Cancer | Phase 1 / Phase 2 | Unknown | The First Affiliated Hospital of Zhengzhou University | 64 | 2022-06-01 | 2022-08-18 |
| Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors NGM438, Pembrolizumab (KEYTRUDA ®) - Pancreatic Cancer, Breast Cancer | Phase 1 | Unknown | NGM Biopharmaceuticals, Inc | 71 | 2022-05-11 | 2024-04-01 |
| Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC Thalidomide Combined With Chemotherapy and Monotherapy - Gastric Cancer Metastatic to Liver | Phase 1 / Phase 2 | Unknown | Qilu Hospital of Shandong University | 106 | 2022-03-10 | 2022-01-20 |
Showing 20 of 99. Sign in to see all of them.
Stomach Neoplasms (92) · Colorectal Neoplasms (19) · Breast Neoplasms (17) · Pancreatic Neoplasms (17) · Carcinoma, Hepatocellular (13) · Esophageal Neoplasms (13) · Carcinoma, Non-Small-Cell Lung (12) · Colonic Neoplasms (8) · Neoplasm Metastasis (8) · Ovarian Neoplasms (8) · Carcinoma, Renal Cell (6) · Neoplasms (6) · Cholangiocarcinoma (5) · Lung Neoplasms (5) · Melanoma (5)
Digestive System Diseases (99) · Gastrointestinal Diseases (99) · Digestive System Neoplasms (92) · Neoplasms by Site (92) · Gastrointestinal Neoplasms (90) · Neoplasms (88) · Neoplasms by Histologic Type (30) · Intestinal Diseases (27) · Neoplasms, Glandular and Epithelial (26) · Intestinal Neoplasms (25) · Colonic Diseases (24) · Carcinoma (23) · Endocrine System Diseases (23) · Skin Diseases (23)
Paclitaxel (11) · Capecitabine (6) · Oxaliplatin (6) · S 1 (combination) (6) · apatinib (5) · pembrolizumab (5) · Cyclophosphamide (4) · Nivolumab (4) · Trastuzumab (4) · Drug Therapy (3) · Injections (3) · Ramucirumab (3) · Cisplatin (2) · Doxorubicin (2) · Immunotherapy, Adoptive (2)
National University Hospital, Singapore (5) · Huiqiang Huang (3) · Seoul National University Bundang Hospital (3) · Beijing Doing Biomedical Co., Ltd. (2) · Chinese Academy of Medical Sciences (2) · Chongqing Precision Biotech Co., Ltd (2) · Hanmi Pharmaceutical Company Limited (2) · Minneamrita Therapeutics LLC (2) · NGM Biopharmaceuticals, Inc (2) · PersonGen BioTherapeutics (Suzhou) Co., Ltd. (2) · Ruijin Hospital (2) · Shanghai Zhongshan Hospital (2) · Shenzhen BinDeBio Ltd. (2) · Yonsei University (2) · Anhui Provincial Hospital (1)
China (45) · South Korea (22) · United States (13) · Singapore (5) · Australia (3) · Japan (2) · Taiwan (2) · Belgium (1) · Colombia (1) · Denmark (1) · France (1) · Germany (1) · Malaysia (1) · Russia (1) · Switzerland (1)
Lin Shen (2) · Lin Yang, Ph.D. (2) · Anish Thomas, MD (1) · Anwaar Saeed, MD (1) · Baorui Liu, MD (1) · Birendra K Sah, PH D (1) · Bok Yan Jimmy So, MBChB (1) · Chen Li, PH D (1) · Cheng Qian, MD, PhD (1) · Dae Young Zang, Dr (1) · David Cutler, MD (1) · Fei Li, M.D (1)
PMID 16564913, PMID 19731245, PMID 20371346, PMID 20959411, PMID 22589701, PMID 24497570, PMID 24641416, PMID 25621950, PMID 25631767, PMID 25805929, PMID 25983002, PMID 26112004, PMID 27347147, PMID 27916294, PMID 28054442, PMID 28161329, PMID 28412099, PMID 28415728, PMID 29506548, PMID 29587677, PMID 29743043, PMID 30089457, PMID 30348638, PMID 30911663, PMID 31164456, PMID 31400383, PMID 31409768, PMID 31432232, PMID 31739095, PMID 31819192, PMID 32711004, PMID 32898333, PMID 33184339, PMID 33462499, PMID 34877867, PMID 34965951, PMID 34998048, PMID 35219300, PMID 35276694, PMID 35460043, PMID 35582564, PMID 35751496, PMID 36224176, PMID 36441083, PMID 36907947, PMID 37036671, PMID 37104017, PMID 37364218, PMID 37563608, PMID 37634629
2016 (1), 2018 (1), 2023 (1)